Cardioprotective effect of propofol in cardioplegia compared to systemic propofol in heart valves surgery; a randomized controlled trial
Tóm tắt
Myocardial protection is still a focus of ongoing research. Propofol is used widely during the induction of anaesthesia in cardiac surgery. So, this triggers us to investigate the cardioprotective effect of the propofol when added to the cardioplegia compared to systemic propofol by measuring the troponin T level. This clinical randomized controlled trial was carried out on 150 patients operated for elective valvular heart surgery. Patients were assigned into three equal groups: Group 1: received propofol in the cardioplegia, Group 2: received propofol injection in the aortic line before and after the aortic cross-clamp, and Group 3 (control group): patients without propofol in the cardioplegia or aortic line. All patients were subjected to full medical histories, physical examinations, routine tests, and echocardiography. Cardiac troponin T was measured before surgery and 4 times postoperatively. In group 1, there was a significant improvement in troponin T level at the last reading compared with the control group (mean ± SD. of group 1 was 246.4 ± 131.4, mean ± SD. of group 3 was 317.0 ± 117.9, p = 0.031), denoting propofol's cardioprotective effect when added as a cardioplegia additive. In group 2, there was a significant improvement of troponin T level at the last reading compared with the group 1 and control group (mean ± SD. of group 2 was 202.54 ± 156.03, mean ± SD. of group 3 was 317.0 ± 117.9, p < 0.001), denoting propofol's more cardioprotective effect when used systemically during cardiopulmonary bypass than when added as a cardioplegia additive. In valvular cardiac surgery, propofol has an additional cardioprotective effect and a superior cardiac outcome when administered systematically during cardiopulmonary bypass rather than added to cardioplegia. Pan African Clinical Trials Register PACTR201907764652028. Registered on 01 July 2019, retrospectively registered,
https://pactr.samrc.ac.za/
TrialDisplay.aspx?TrialID = 5726.
Tài liệu tham khảo
Chambers DJ, Fallouh HB (2010) Cardioplegia and cardiac surgery: pharmacological arrest and cardioprotection during global ischemia and reperfusion. Pharmacol Ther 127:41–52
Kloner RA, Rezkalla SH (2004) Cardiac protection during acute myocardial infarction: where do we stand in? J Am Coll Cardiol 44:276–286
Vinten-Johansen J, Thourani VH (2000) Myocardial protection: an overview. J Extra Corpor Technol 32:38–48
Bovill JG (2006) Intravenous anesthesia for the patient with left ventricular dysfunction. Semin Cardiothorac Vasc Anesth 10:43–48
Aydin M, Berna E, Sennur K et al (2009) Dose dependent effects of propofol on expression ICAM-1 in rabbit aorta endothelial cells. Afr J Biotech 23:6688–6693
Kamada N, Kanaya N, Hirata N et al (2008) Cardioprotective effects of propofol in isolated ischemia-reperfused guinea pig hearts: role of KATP channels and GSK-3beta. Can J Anaesth 55:595–605
Xia Z, Godin DV, Chang TK et al (2003) Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15–F2t-isoprostane formation. Can J Physiol Pharmacol 81:14–21
Kato R, Foëx P (2002) Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists. Can J Anaesth 49:777–791
Soraas CL, Friis C, Engebretsen KV et al (2012) Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery. Am Heart J 164:779–785
Yamamoto H, Yamamoto F (2013) Myocardial protection in cardiac surgery: a historical review from the beginning to the current topics. Gen Thorac Cardiovasc Surg 61:485–496
Rogers CA, Bryan AJ, Nash R et al (2015) Propofol cardioplegia: A single-center, placebo-controlled, randomized controlled trial. J Thorac Cardiovasc Surg 150:1610–1619
Samir A, Gandreti N, Madhere M et al (2015) Anti-inflammatory effects of propofol during cardiopulmonary bypass: a pilot study. Ann Card Anaesth 18:495–501
Corcoran TB, Engel A, Sakamoto H et al (2004) The effects of propofol on lipid peroxidation and inflammatory response in elective coronary artery bypass grafting. J Cardiothorac Vasc Anesth 18:592–604